These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9636505)

  • 1. Elective conversion of patients from cyclosporine to tacrolimus for hypertrichosis.
    Fernando ON; Sweny P; Varghese Z
    Transplant Proc; 1998 Jun; 30(4):1243-4. PubMed ID: 9636505
    [No Abstract]   [Full Text] [Related]  

  • 2. Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis.
    Busque S; Demers P; St-Louis G; Boily JG; Tousignant J; Lemieux F; Smeesters C; Corman J; Daloze P
    Transplant Proc; 1998 Jun; 30(4):1247-8. PubMed ID: 9636507
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and efficacy of tacrolimus rescue therapy in 55 kidney transplant patients treated with cyclosporine.
    Urbizu JM; Zárraga S; Gómez-Ullate P; Amenábar JJ; Gaínza FI; Lampreabe I; Virto J; Orbe J
    Transplant Proc; 2003 Aug; 35(5):1704-5. PubMed ID: 12962765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion from cyclosporine A to tacrolimus after kidney transplantation due to hyperlipidemia.
    Kohnle M; Zimmermann U; Lütkes P; Albrecht KH; Philipp T; Heemann U
    Transpl Int; 2000; 13 Suppl 1():S345-8. PubMed ID: 11112029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion from cyclosporine to tacrolimus prevents transplant function loss due to acute steroid-resistant or chronic rejection in renal allograft recipients.
    Blume C; Hollenbeck M; Ivens K; Heering P; Hetzel GR; Grabensee B
    Transplant Proc; 2001; 33(7-8):3161-3. PubMed ID: 11750357
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of conversion from cyclosporine to tacrolimus on lipid profiles in renal transplant recipients.
    Colak T; Karakayali H; Yagmurdur MC; Moray G
    Transplant Proc; 2002 Sep; 34(6):2081-2. PubMed ID: 12270321
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hypertrichosis and gingival hypertrophy regression in renal transplants following the substitution of cyclosporin by tacrolimus].
    Busque S; Demers P; Saint-Louis G; Boily JG; Tousignant J; Lemieux F; Martin G; Smeesters C; Corman J; Daloze P
    Ann Chir; 1999; 53(8):687-9. PubMed ID: 10584376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion to tacrolimus once-daily from ciclosporin in stable kidney transplant recipients: a multicenter study.
    Rostaing L; Sánchez-Fructuoso A; Franco A; Glyda M; Kuypers DR; Jaray J
    Transpl Int; 2012 Apr; 25(4):391-400. PubMed ID: 22211928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion from tacrolimus to Neoral in liver and kidney transplant recipients.
    Ott R; Bussenius-Kammerer M; Scholz D; Neuhaus R; Tolba RH; Fricke L; Müller V
    Transplant Proc; 2001; 33(7-8):3166-8. PubMed ID: 11750359
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized conversion from cyclosporine to tacrolimus in renal transplant patients: improved lipid profile and unchanged plasma homocysteine levels.
    Artz MA; Boots JM; Ligtenberg G; Roodnat JI; Christiaans MH; Hené RJ; Blom HJ; Demacker PN; Hilbrands LB
    Transplant Proc; 2002 Aug; 34(5):1793-4. PubMed ID: 12176579
    [No Abstract]   [Full Text] [Related]  

  • 11. Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience.
    Alloway RR; Russell WC; Gaber LW; Amiri MH; Vera SR; Gaber AO
    Transplant Proc; 1996 Apr; 28(2):995-7. PubMed ID: 8623494
    [No Abstract]   [Full Text] [Related]  

  • 12. Improvement of cardiovascular risk factors and cosmetic side effects in kidney transplant recipients after conversion to tacrolimus.
    Zadrazil J; Horak P; Zahalkova J; Strebl P; Horcicka V; Krejci K; Bachleda P; Dedochova J; Valkovsky I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):67-73. PubMed ID: 19365530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion from cyclosporine to tacrolimus is preferred by pediatric renal transplant recipients: a focus on opinions and outcomes.
    Sundberg AK; Smith LD; Somerville KT; Cox R; Sherbotie JR
    Transplant Proc; 2002 Aug; 34(5):1951-2. PubMed ID: 12176640
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts.
    Copley JB; Staffeld C; Lindberg J; Hansen A; Bailey C; Anand R; Van Veldhuisen P
    Transplant Proc; 1998 Jun; 30(4):1254-6. PubMed ID: 9636510
    [No Abstract]   [Full Text] [Related]  

  • 15. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
    Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term renal and pancreas function with tacrolimus rescue therapy following kidney/pancreas transplantation.
    Hariharan S; Peddi VR; Munda R; Demmy AM; Schroeder TJ; Alexander JW; First MR
    Transplant Proc; 1997; 29(1-2):652-3. PubMed ID: 9123462
    [No Abstract]   [Full Text] [Related]  

  • 17. Conversion to tacrolimus in hyperlipidemic patients.
    Friemann S; Stopp K; Christ B; Weimer R; Padberg W; Ernst W
    Transplant Proc; 1999 Nov; 31(7A):41S-43S. PubMed ID: 10576042
    [No Abstract]   [Full Text] [Related]  

  • 18. Conversion to tacrolimus in cyclosporin A treated patients with gum hyperplasia.
    Kohnle M; Lütkes P; Witzke O; Philipp T; Heemann U
    Transplant Proc; 1998 Aug; 30(5):2122-3. PubMed ID: 9723413
    [No Abstract]   [Full Text] [Related]  

  • 19. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
    Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
    Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
    [No Abstract]   [Full Text] [Related]  

  • 20. Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus.
    Friemann S; Feuring E; Padberg W; Ernst W
    Transplant Proc; 1998 Jun; 30(4):1240-2. PubMed ID: 9636504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.